Background: Hearing, visual, and olfactory impairments have been associated with cognitive impairment in older adults but less is known about associations with cognitive function in middle-aged adults. Methods: Sensory and cognitive functions were measured on participants in the baseline examination (2005)(2006)(2007)(2008) Pure-tone audiometry, Pelli-Robson letter charts, and the San Diego Odor Identification test were used to measure hearing, contrast sensitivity, and olfaction, respectively. Results: There were 2,836 participants aged 21-84 years with measures of hearing, visual, olfactory, and cognitive function at the baseline examination. Nineteen percent of the cohort had one sensory impairment and 3% had multiple sensory impairments. In multivariable adjusted linear regression models that included all three sensory impairments, hearing impairment, visual impairment, and olfactory impairment were each independently associated with poorer performance on the TMTA, TMTB, and Grooved Peg Board (p < .05 for all sensory impairments in all models). Participants with a sensory impairment took on average from 2 to 10 seconds longer than participants without the corresponding sensory impairment to complete these tests. Results were similar in models that included adjustment for hearing aid use. Conclusion: Hearing, visual and olfactory impairment were associated with poorer performance on cognitive function tests independent of the other sensory impairments and factors associated with cognition. Sensory impairments in midlife are associated with subtle deficits in cognitive function which may be indicative of early brain aging.
Positive associations between impairments in sensory functions, either hearing, vision or olfaction and cognitive impairment in older adults are fairly well established in the literature (1) (2) (3) (4) (5) (6) (7) . An exploratory workshop sponsored by the National Institute on Aging in 2010, concluded that sensory regions of the central nervous system (CNS) are affected by Alzheimer pathology and deficits in hearing, vision and olfaction precede cognitive symptoms of clinical Alzheimer's disease (AD) (8) . Most previous studies focused on the relationship between a single sensory impairment and cognitive impairment and did not account for possible impairments in the other sensory systems. However, the Epidemiology of Hearing Loss Study (EHLS) recently reported that when modeled together hearing, visual, and olfactory impairment were each significantly and independently associated with the development of cognitive impairment suggesting impairments in these sensory systems may be indicators of brain aging (1) .
Less is known about the relationship between sensory impairments and cognitive function in middle-aged adults. Whereas cognitive impairment is rare, it has been shown that cognitive decline and age-related pathophysiological brain changes can begin in mid-life (9) (10) (11) . The onset of age-related sensory impairments also begins in mid-life and the prevalence of these impairments becomes more common as people get older (12) (13) (14) . In a small study of hearing, vision and cognitive function, sensory and cognitive processing were both worse in middle-aged adults versus young adults but better than in older adults (10) , though another recent study found no association between hearing loss and cognition in adults aged 45-66 years (15) . Olfactory impairment has also been associated with worse performance on cognitive function tests in this age group (16) but studies of all three senses (hearing, vision, and olfaction) and cognitive function in middle-aged adults are lacking. The purpose of this study was to determine if hearing, visual, and olfactory impairment are independently associated with cognitive function in a primarily middle-aged cohort.
Methods
The Beaver Dam Offspring Study (BOSS) is a longitudinal cohort study of sensory health and aging in the adult children of participants in the longitudinal population-based EHLS (12, 17, 18) . The baseline (2005) (2006) (2007) (2008) ) BOSS examination included measures of hearing, olfaction, vision, and cognitive function (19) . Informed written consent was obtained from all participants prior to each examination and approval for these studies was obtained from the University of Wisconsin Health Sciences Institutional Review Board.
Cognitive Function Measures
The Trail Making Test-A (TMTA), Trail Making Test-B (TMTB) and the Grooved Peg Board (GPB; Lafayette Instruments, Lafayette, IN) were administered at the baseline examination (20, 21) The scores for the TMTA, TMTB, and GPB were the time it took in seconds(s) to successfully complete each test with a longer time indicating poorer performance. Participants unable to complete the test in the allotted 5 minutes were assigned a score of 301 seconds.
Sensory Measures
Hearing was measured in a sound treated booth using pure-tone air-(0.5, 1, 2, 3, 4, 6, and 8 kHz) and bone-conduction (0.5, 2, and 4 kHz) audiometry following the guidelines of the American SpeechLanguage-Hearing Association (17, 22) . Hearing impairment was defined as a pure-tone average of the thresholds at 0.5, 1, 2, and 4 kHz greater than 25 dB Hearing Level in either ear (17) . Olfaction was measured using the eight-item San Diego Odor Identification Test. The score is the number of odorants correctly identified (0-8) after two trials (13, 18) . Olfactory impairment was defined as identifying fewer than six odorants correctly. Contrast Sensitivity was measured in each eye separately using Pelli-Robson letter charts. The measurement unit was log contrast sensitivity units based on triplet scores and visual impairment was defined as contrast sensitivity less than 1.55 log units in the better eye (23) .
Covariates that were available from data collected at the baseline examination and evaluated as potential confounders included hypertension, waist circumference, carotid artery plaque, hemoglobin A1C, non-high-density lipoprotein (HDL) cholesterol, inflammatory marker levels (high-sensitivity C-reactive protein [ 
Statistical Analyses
All analyses were conducted with SAS 9.4 (SAS Institute, Inc., Cary, NC). Ordinary linear regression was used to determine the associations between baseline sensory impairments and TMTA, TMTB, and GPB scores. To account for sensory comorbidities and determine the independent association of each sensory impairment with each cognitive outcome, hearing, visual, and olfactory impairment, were included together in all models. Stepwise linear regression was used to explore potential confounders of the associations between sensory impairments and cognitive function. Variables were allowed to enter at a set significance level of 0.25 and remained in this preliminary model at the required significance of 0.10. To have a common set of covariates in all models, if a covariate was retained in any of the models by the stepwise procedure it was included in the final model for each of the cognitive outcomes. To evaluate if relationships in those less than 65 years were the same as the whole cohort, the final models were repeated excluding participants 65 years or older.
Results
There were 2,836 participants at baseline with hearing, vision, olfaction, and cognitive function data that were included in this study. Participants were a mean age of 49 years (range 21-84 years; Table 1) The most common sensory impairment was hearing (14.2%) followed by visual (7.8%) and olfactory (3.8%) impairments.
In ordinary linear regression models including age and sex, hearing, visual, and olfactory impairment, when modeled together, were each independently associated with significantly worse performance on the TMTA, TMTB, and GPB. (Table 2 ) Participants with a sensory impairment took on average from 2 to 15 seconds longer than participants without the corresponding sensory impairment to complete these tests (Table 2) . For example, after adjusting for age, sex, olfactory, and visual impairment, participants with hearing impairment took on average 2, 7, and 5 seconds longer to complete the TMTA, TMTB, and GPB, respectively, compared to participants without hearing impairment (Table 2) . Because the three sensory impairments are modeled together the estimates in the models are considered additive. Therefore, if a participant had impairment of all three senses, the estimated time to complete the TMTA, TMTB, and GPB on average would be 14, 35, and 17 seconds longer, respectively, than the time for a participant with no sensory impairments. After further adjustment, each sensory impairment remained independently associated (p < .05 for all sensory impairments in all models) with poorer performance on the TMTA, TMTB, and GPB when modeled together (Table 2 ). Adjusting for current hearing aid use did not modify the association between hearing impairment and cognitive test performance (results not shown). The final adjusted models were repeated excluding those 65 years and older and results were similar.
Discussion
In this study of primarily middle-aged adults, participants with sensory impairments had poorer performance on cognitive function tests. Hearing, visual, and olfactory impairment were each significantly associated with worse cognitive function independent of other sensory impairments and after adjustment for other factors associated with cognition including depressive symptoms, inflammatory marker levels, and vascular risk factors. Results from the current study extend the recent findings from the older EHLS population into a younger cohort and with cognitive function versus impairment (1).
These results from a large well-defined cohort with standard measures of sensory and cognitive function and extensive covariate data, support the hypothesis that because auditory, visual, and olfactory signals are ultimately processed in the brain, sensory, and cognitive functions may be contemporarily affected by underlying pathophysiological changes related to aging or disease (1, 24) . For example, AD pathology has been found to be present in the central neural pathways of the auditory, visual and olfactory systems and in the peripheral neural pathways of the visual and olfactory systems (8) . Midlife cardiovascular risk factors have also been associated with cognitive function (25, 26) and carotid atherosclerosis has been previously associated with hearing impairment and olfactory and cognitive function in this cohort (19, 25, 27 ), however we controlled for these factors in the analyses suggesting there are likely many underlying mechanisms that contribute to these aging changes.
Limitations in this study include the availability of only three cognitive functions measures at baseline and the broad age range of participants, however, the cognitive tests used are well-established measures of processing and executive function and over 90% of participants were less than age 65 years. Sensitivity analyses limited to participants less than 65 years yielded similar results strengthening the evidence that the co-occurrence of changes in sensory and cognitive function begins in midlife. In conclusion, sensory impairments in midlife are associated with subtle deficits in cognitive function which could be indicative of early neural changes and brain aging. Note: ICAM = intracellular adhesion molecule; TNF = tumor necrosis factor; VCAM = vascular cell adhesion molecule. All sensory impairments included together in all models.
